Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chest discomfort, Chest pain, Costochondritis, Dyspnoea
Clinical narrative: costochondritis; chest wall pain; didn't get any better; sharp shooting pain in her heart; sharp shooting pain in her back; felt a gush of hot blood going through her chest; she started feeling not just pain in her arm but also; tightness in her chest; hard time breathing; Though it was a blood clot; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Though it was a blood clot) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052CVIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Endometriosis and Sjogren's. Concomitant products included HYDROXYCHLOROQUINE for an unknown indication.    On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jul-2021, the patient experienced CHEST DISCOMFORT (felt a gush of hot blood going through her chest). On 08-Jul-2021, the patient experienced COSTOCHONDRITIS (costochondritis), MUSCULOSKELETAL CHEST PAIN (chest wall pain), MALAISE (didn't get any better), CHEST PAIN (sharp shooting pain in her heart) and BACK PAIN (sharp shooting pain in her back). In July 2021, the patient experienced THROMBOSIS (Though it was a blood clot) (seriousness criterion medically significant), PAIN IN EXTREMITY (she started feeling not just pain in her arm but also), CHEST DISCOMFORT (tightness in her chest) and DYSPNOEA (hard time breathing). The patient was treated with KETOROLAC for Adverse event, at a dose of 30 milligram per millilitre and IBUPROFEN for Adverse event, at a dose of 800 mg. At the time of the report, THROMBOSIS (Though it was a blood clot), CHEST DISCOMFORT (felt a gush of hot blood going through her chest), PAIN IN EXTREMITY (she started feeling not just pain in her arm but also), CHEST DISCOMFORT (tightness in her chest), COSTOCHONDRITIS (costochondritis), DYSPNOEA (hard time breathing), MUSCULOSKELETAL CHEST PAIN (chest wall pain), MALAISE (didn't get any better), CHEST PAIN (sharp shooting pain in her heart) and BACK PAIN (sharp shooting pain in her back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, SARS-CoV-2 test: positive (Positive) positive.         She got a chest X-ray, an ECG, a blood differential test, a CBC with differential, a comprehensive metabolic panel, a troponin I test, a D-dimer quantitative test, POC lactic acid panel with a laboratory lactic acid/lactate, oxygen therapy and an urine analysis. The final report results were Chest pain and Lungs normal. No evidence of airspace disease. No plural effusion and No acute abnormally of the thorax. she had an IV at ER.She didn't require hospitalization or treatment for Covid. She stayed home for the duration of the infection and she only talked to her rheumatologist by the phone.  Company Comment: This case concerns a 29 AGE year-old, female with a history of COVID-19 in february, 2021, endometriosis and Sjogren's , who experienced the unexpected events of THROMBOSIS (seriousness criterion medically significant), PAIN ARM, CHEST DISCOMFORT, DYSPNOEA, COSTOCHONDRITIS, MUSCULOSKELETAL CHEST PAIN, MALAISE, CHEST PAIN and BACK PAIN. The events occurred approximately 7 days after the first dose of mRNA-1273 Moderna vaccine. The events are consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of mRNA-1273 Moderna vaccine in not affected by this report.   This case was linked to MOD-2021-319833 (Patient Link).   Reporter did not allow further contact; Sender's Comments: This case concerns a 29 AGE year-old, female with a history of COVID-19 in february, 2021, endometriosis and Sjogren's , who experienced the unexpected events of THROMBOSIS (seriousness criterion medically significant), PAIN ARM, CHEST DISCOMFORT, DYSPNOEA, COSTOCHONDRITIS, MUSCULOSKELETAL CHEST PAIN, MALAISE, CHEST PAIN and BACK PAIN. The events occurred approximately 7 days after the first dose of mRNA-1273 Moderna vaccine. The events are consistent with the current understanding of the mechanism of action of the study medication. The benefit-risk relationship of mRNA-1273 Moderna vaccine in not affected by this report